Mesalamine Capsule, Extended Release
Product Images NDC 0378-1375

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0378-1375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mesalamine Structural Formula (Image 01)

Each capsule contains 0.375 g of mesalamine, USP as enteric-coated pellets. This medication is typically prescribed, and more information on its usual dosage can be found in the accompanying prescribing information. It should be kept out of reach of children and stored at a controlled room temperature between 20° to 25°C. The capsules are manufactured for Mylan Pharmaceuticals Inc. in Morgantown, USA, and are made in India. The medicine is dispensed in a tight, light-resistant container with a child-resistant closure. The container must be kept tightly closed, and it has variable data coding. The GTIN is available, and there is a free area for the date of expiration and lot number.*

FDA Label Image

Mesalamine Extended-release Capsules, Usp 0.375 G Bottle Label (Image 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.